A detailed history of Congress Asset Management CO transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Congress Asset Management CO holds 433,865 shares of CRL stock, worth $80.8 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares
433,865
Previous 443,104 2.09%
Holding current value
$80.8 Million
Previous $91.5 Million 6.63%
% of portfolio
0.6%
Previous 0.67%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$187.96 - $245.29 $1.74 Million - $2.27 Million
-9,239 Reduced 2.09%
433,865 $85.5 Million
Q2 2024

Aug 02, 2024

SELL
$206.39 - $268.73 $2.12 Million - $2.76 Million
-10,288 Reduced 2.27%
443,104 $91.5 Million
Q1 2024

Apr 11, 2024

SELL
$203.52 - $273.43 $2.41 Million - $3.24 Million
-11,866 Reduced 2.55%
453,392 $123 Million
Q4 2023

Mar 04, 2024

SELL
$164.52 - $238.84 $541,928 - $786,738
-3,294 Reduced 0.7%
465,258 $110 Million
Q3 2023

Nov 01, 2023

BUY
$194.44 - $217.61 $281,160 - $314,664
1,446 Added 0.31%
468,552 $91.8 Million
Q2 2023

Jul 27, 2023

BUY
$183.71 - $210.25 $89,283 - $102,181
486 Added 0.1%
467,106 $98.2 Million
Q1 2023

Apr 21, 2023

BUY
$191.89 - $259.92 $2.72 Million - $3.69 Million
14,180 Added 3.13%
466,620 $94.2 Million
Q4 2022

Jan 18, 2023

SELL
$197.11 - $250.07 $5.82 Million - $7.39 Million
-29,537 Reduced 6.13%
452,440 $0
Q3 2022

Nov 08, 2022

BUY
$182.44 - $250.54 $3.69 Million - $5.07 Million
20,222 Added 4.38%
481,977 $94.9 Million
Q2 2022

Aug 02, 2022

BUY
$204.13 - $302.4 $1.82 Million - $2.69 Million
8,910 Added 1.97%
461,755 $98.8 Million
Q1 2022

Apr 20, 2022

BUY
$255.51 - $362.11 $4.95 Million - $7.01 Million
19,355 Added 4.46%
452,845 $129 Million
Q4 2021

Jan 28, 2022

SELL
$351.38 - $448.68 $4.84 Million - $6.19 Million
-13,787 Reduced 3.08%
433,490 $163 Million
Q3 2021

Nov 08, 2021

SELL
$372.64 - $458.3 $8.47 Million - $10.4 Million
-22,741 Reduced 4.84%
447,277 $185 Million
Q2 2021

Aug 05, 2021

SELL
$294.17 - $371.65 $18.9 Million - $23.9 Million
-64,317 Reduced 12.04%
470,018 $174 Million
Q1 2021

May 05, 2021

SELL
$249.67 - $299.48 $15.4 Million - $18.5 Million
-61,615 Reduced 10.34%
534,335 $155 Million
Q4 2020

Jan 26, 2021

SELL
$222.0 - $252.62 $3.94 Million - $4.48 Million
-17,727 Reduced 2.89%
595,950 $149 Million
Q3 2020

Nov 03, 2020

SELL
$175.56 - $226.45 $2.97 Million - $3.83 Million
-16,909 Reduced 2.68%
613,677 $139 Million
Q2 2020

Jul 23, 2020

SELL
$118.84 - $189.72 $1.72 Million - $2.75 Million
-14,507 Reduced 2.25%
630,586 $110 Million
Q1 2020

Apr 21, 2020

SELL
$98.9 - $178.34 $3.7 Million - $6.67 Million
-37,399 Reduced 5.48%
645,093 $81.4 Million
Q4 2019

Feb 10, 2020

SELL
$126.05 - $152.76 $363,906 - $441,018
-2,887 Reduced 0.42%
682,492 $104 Million
Q3 2019

Nov 01, 2019

SELL
$125.07 - $143.67 $2.19 Million - $2.51 Million
-17,486 Reduced 2.49%
685,379 $90.7 Million
Q2 2019

Aug 07, 2019

SELL
$123.4 - $148.55 $6.04 Million - $7.28 Million
-48,983 Reduced 6.52%
702,865 $99.7 Million
Q1 2019

May 08, 2019

SELL
$104.82 - $146.73 $1.75 Million - $2.45 Million
-16,686 Reduced 2.17%
751,848 $109 Million
Q4 2018

Jan 25, 2019

SELL
$105.09 - $137.23 $4.59 Million - $5.99 Million
-43,672 Reduced 5.38%
768,534 $87 Million
Q3 2018

Oct 26, 2018

SELL
$112.11 - $134.54 $1.71 Million - $2.05 Million
-15,235 Reduced 1.84%
812,206 $109 Million
Q2 2018

Jul 25, 2018

SELL
$102.37 - $117.25 $383,682 - $439,453
-3,748 Reduced 0.45%
827,441 $92.9 Million
Q1 2018

May 11, 2018

BUY
$98.19 - $115.2 $5.88 Million - $6.9 Million
59,910 Added 7.77%
831,189 $88.7 Million
Q4 2017

Jan 30, 2018

BUY
$100.43 - $118.09 $1.53 Million - $1.8 Million
15,201 Added 2.01%
771,279 $84.4 Million
Q3 2017

Oct 17, 2017

BUY
$96.72 - $109.26 $73.1 Million - $82.6 Million
756,078
756,078 $81.7 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.48B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Congress Asset Management CO Portfolio

Follow Congress Asset Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Congress Asset Management CO , based on Form 13F filings with the SEC.

News

Stay updated on Congress Asset Management CO with notifications on news.